Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Vitamin D Supplementation in First Episode Schizophrenia: A Double Blind Controlled Study

NCT03101319 is registered in ClinicalTrials.gov with Central Institute of Psychiatry, Ranchi, India as lead sponsor.

NCT NCT03101319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03101319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Vitamin D Supplementation in First Episode Schizophrenia: A Double Blind Controlled Study
Lead sponsor
Central Institute of Psychiatry, Ranchi, India
Phase
Not applicable
Overall status
Completed
Start date
April 8, 2019
Completion date
June 22, 2021
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia